The Association of Women with Breast Cancer (DACMA) has donated a check for 8,000 euros to IDIBELl and ICO dedicated to breast cancer research. This donation counted on the participation of Belén García, the mayor of Sant Joan Despí, where DACMA has its headquarters, who wanted to accompany the entity members in this event.

The patients were received by the ICO l’Hospitalet’s territorial director, Jordi Trelis, and the IDIBELL director, Gabriel Capellá, who thanked them for their involvement and collaboration in research for fighting this disease. The medical oncologist specialized in breast cancer at the ICO l’Hospitalet, Sònia Pernas, has been in charge of explaining the project where this money will be invested and has reiterated her gratitude to the association.

Besides, both the organization’s president and the mayor of Sant Joan Despí, have highlighted their involvement in the fight against this disease, which has somehow closely affected all members of the entity. 

This organization has currently more than 120 members in the city of Sant Joan Despí and its purpose is to support all those people who have suffered from this disease.

The Bellvitge Biomedical Research Institute (IDIBELL) is a biomedical research center created in 2004. It is participated by the Bellvitge University Hospital and the Viladecans Hospital of the Catalan Institute of Health, the Catalan Institute of Oncology, the University of Barcelona and the City Council of L’Hospitalet de Llobregat.

IDIBELL is a member of the Campus of International Excellence of the University of Barcelona HUBc and is part of the CERCA institution of the Generalitat de Catalunya. In 2009 it became one of the first five Spanish research centers accredited as a health research institute by the Carlos III Health Institute. In addition, it is part of the “HR Excellence in Research” program of the European Union and is a member of EATRIS and REGIC. Since 2018, IDIBELL has been an Accredited Center of the AECC Scientific Foundation (FCAECC).